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Naegeli–Franceschetti–Jadassohn syndrome (NFJS) is a rare autosomal dominant disorder characterized by loss of
dermatoglyphics, reticulate hyperpigmentation of the skin, palmoplantar keratoderma, abnormal sweating, and
other developmental anomalies of the teeth, hair, and skin. We recently demonstrated that NFJS is caused by
heterozygous nonsense or frameshift mutations in the E1/V1-encoding region of KRT14, but the mechanisms for
their deleterious effects in NFJS remain elusive. In this study, we further expand the spectrum of NFJS-causing
mutations and demonstrate that these mutations result in haploinsufficiency for keratin 14 (K14). As increased
apoptotic activity was observed in the epidermal basal cell layer in NFJS patients and as previous data suggested that
type I keratins may confer resistance to tumor necrosis factor-a (TNF-a)-induced apoptosis in epithelial tissues,
we assessed the effect of down-regulation of KRT14 expression on apoptotic activity in keratinocytes. Using a
HaCaT cell-based assay, we found that decreased KRT14 expression is associated with increased susceptibility to
TNF-a-induced apoptosis. This phenomenon was not observed when cells were cultured in the presence of
doxycycline, a known negative regulator of TNF-a-dependant pro-apoptotic signaling. Collectively, our results
indicate that NFJS results from haploinsufficiency for K14 and suggest that increased susceptibility of keratinocytes
to pro-apoptotic signals may be involved in the pathogenesis of this ectodermal dysplasia syndrome.
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INTRODUCTION
Naegeli–Franceschetti–Jadassohn syndrome (NFJS; MIM161000)
is a rare autosomal dominant form of ectodermal dysplasia
characterized by partial or complete absence of dermato-
glyphics, reticulate hyperpigmentation of the skin, palmoplantar
keratoderma, abnormal regulation of sweating, dental ano-
malies, and nail dystrophy (Itin et al., 1993). Linkage analysis
initially located the NFJS gene to a 6 cM interval on
17q11.2–q21 (Whittock et al., 2000; Sprecher et al., 2002),
harboring a cluster of type I keratin genes. More recently,
candidate gene screening led to the identification of auto-
somal dominant nonsense or frameshift mutations in the KRT14
gene in five families of various ethnic origins (Lugassy et al.,
2006).
Mutations in KRT14 have previously been shown to
underlie a different inherited disorder, epidermolysis bullosa
simplex (EBS; MIM 131800, 131760, 131900). Indeed, more
than 60 autosomal dominant and recessive mutations in
KRT14 (http://www.interfil.org) have been reported in this
skin fragility disorder, which is characterized by blistering of
the skin following mechanical trauma (Irvine, 2005). In
contrast to NFJS, loss of dermatoglyphics has never been
reported in EBS, and abnormal pigmentation has been limited
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to a rare EBS subtype (EBS with mottled pigmentation) (Uttam
et al., 1996; Horiguchi et al., 2005; Harel et al., 2006). Blister
formation in autosomal dominant EBS results from a
dominant negative effect of faulty keratin molecules, which
weaken the intracellular keratin intermediate filament net-
work (Omary et al., 2004; Uitto et al., 2007).
In contrast to EBS, congenital blistering is infrequent and
rarely persistent in NFJS patients. Tonofilament formation
is mostly normal, although subtle abnormalities in the
supramolecular organization of keratin intermediate fila-
ments have been observed (Lugassy et al., 2006). These
data suggest that different mechanisms may underlie the
pathogenesis of EBS and NFJS.
In this study, we report a previously unknown NFJS-
causing mutation in KRT14, demonstrate that NFJS is
associated with haploinsufficiency for keratin 14 (K14), and
implicate for the first time an increased susceptibility of
keratinocytes to pro-apoptotic signals in the pathogenesis of
this ectodermal dysplasia syndrome.
RESULTS
The spectrum of NFJS-causing mutations in KRT14
We evaluated a female individual with cutaneous findings
suggestive of NFJS. At 8 years of age, when the diagnosis was
established, she showed mottled hyperpigmentation of the
skin, predominantly on the trunk (Figure 1a), and epidermal
ridge dissociation of finger and toe tips (Figure 1b). Other
findings included skin atrophy over the knuckles and palms,
hypohidrosis, abnormal dentition, slowly growing hair, and
occasional skin blistering on the arms and legs. Family history
was unremarkable. A skin biopsy obtained from a hyperpig-
mented macule showed several foci of apoptosis in the basal
cell layer as well as numerous melanophages in the upper
dermis (Figure 1c). No expression of K6a or K16 was
observed in the epidermis of this patient (not shown).
To confirm NFJS at the molecular level, we sequenced the
entire coding region of the KRT14 gene (including exon–
intron boundaries) and identified a previously unknown,
heterozygous single-nucleotide deletion at position 29 of
the complementary DNA (cDNA) nucleotide sequence
(c.29delC, NM_000526), predicted to result in frameshift
and termination of protein translation due to a premature
termination codon positioned 8 amino acids downstream to
the mutation site (Figure 1d). Using DNA chromatography
heteroduplex analysis, we excluded the c.29delC mutation
from a panel of 100 population-matched control chromo-
somes (not shown).
NFJS-causing mutations result in decreased KRT14 mRNA levels
in affected skin
Most KRT14 mutations reported to date have been shown or
are predicted to exert a dominant-negative effect (Omary
et al., 2004; Uitto et al., 2007). In contrast, all NFJS-causing
mutations, including the previously unknown mutation
identified in this study, are early nonsense or frameshift
changes that are expected to cause very premature termina-
tion of translation (Lugassy et al., 2006) and nonsense-
mediated mRNA decay (NMD) (Garneau et al., 2007), thus
resulting in K14 haploinsufficiency. As NFJS mutations are
located very close to the KRT14 initiation codon, it is also
possible that a downstream alternative ATG initiation codon
is utilized, which would protect the mutant KRT14 mRNAs
from nonsense-mediated degradation by allowing re-initia-
tion of protein translation. This mechanism, which has been
demonstrated for a number of recessive disorders (McLean
et al., 2003; Paulsen et al., 2006), would result in amino-
terminally truncated proteins, which in turn could possibly
exert a dominant-negative effect. To determine the impact of
NFJS-causing mutations on KRT14 RNA levels in vivo, we
extracted RNA from skin biopsies obtained from three
patients heterozygous for mutations p.C18X (Lugassy et al.,
2006), p.Q7X (Lugassy et al., 2006) or c.29delC (Figure 1).
Using 6-carboxyfluorescein (FAM)-labeled oligonucleotide
primers, we PCR-amplified patient’s cDNA and genomic
DNA (gDNA), incubated the PCR amplicons with mutation-
specific endonucleases, and analyzed the resulting DNA
fragments using an automated sequencer (Figure 2a). We
estimated mutant mRNA levels relative to wild-type (WT)
mRNA levels as described in ‘‘Materials and Methods’’.
Compared to the WT allele, KRT14 mutant mRNA levels
were markedly decreased (p.Q7X, o1%; p.C18X, B14%;
and c.29delC, B33% of the control), indicating that NFJS-
causing mutations result in substantial (but not complete)
KRT14 mRNA degradation (50% or less) (Figure 2b).
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Figure 1. Clinical and molecular features in NFJS. (a) An 8-year-old patient
displays reticulate pigmentation, most prominently over the trunk; (b) she
also demonstrates lack of dermatoglyphics (upper panel). Patient’s middle
fingerprint on the right reveals ridge dissociation (for comparison, normal
adult thumbprint is shown on the left, lower panel). (c) Histopathological
examination shows discrete focal apoptosis in the basal cell layer (arrow;
hematoxylin and eosin, bar¼ 20mm) as well as numerous melanophages
in the upper papillary dermis (inset, asterisk; hematoxylin and eosin,
bar¼ 40 mm). (d) Mutation analysis reveals a heterozygous single-nucleotide
deletion at cDNA position 29 (c.29delC) (upper panel). The WT sequence is
given for comparison in the lower panel.
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NFJS-causing mutations result in KRT14 haploinsufficiency
To assess the consequences of NFJS-causing mutations at the
protein level, we used HaCaT cells, an immortalized cell line
that retains many, but not all, biological properties of
keratinocytes (Boukamp et al., 1992). These cells were
transfected with WT and p.C18X-carrying expression vectors
coding for a full-length K14–enhanced green fluorescent
protein (EGFP) fusion protein. Neither confocal microscopy
(Figure 3a) nor western blotting (Figure 3b) revealed a gene
product in cells transfected with the mutant construct. In
contrast, the WT K14–EGFP fusion protein fully co-localized
with endogeneous K14, demonstrating that the transfected
expression vector encoded a functional protein (Figure 3a).
Despite the fact that these in vitro data, obtained using KRT14
cDNA, do not exclude the possibility that alternative splice
variants may be generated in vivo, they argue against the
existence of an efficient alternative translation initiation site
located downstream to NFJS-causing mutations.
Decreased KRT14 expression is associated with increased
susceptibility to TNF-a-mediated apoptosis
Histopathological (Figure 1c) and electron microscopic
(Lugassy et al., 2006) examination of skin biopsies suggested
that NFJS may be associated with abnormally elevated
apoptotic activity in the epidermal basal cell layer. Type I
keratins have been shown to block tumor necrosis factor-a
(TNF-a)-mediated pro-apoptotic signals, possibly through
sequestration of TNF receptor type 1-associated death
domain protein (TRADD) (Inada et al., 2001; Yoneda et al.,
2004). As NFJS-causing mutations result in KRT14 haploin-
sufficiency, we assessed the effect of a decrease in KRT14
expression on HaCaT cell susceptibility to TNF-a-mediated
apoptosis. HaCaT cells were exposed to KRT14-specific or
scrambled small interfering RNA (siRNA) in the presence or
absence of recombinant TNF-a. To mimic the in vivo
situation, the concentration of siRNA used was adjusted to
get an B50% decrease in KRT14 expression. We found out
that decreasing the expression of KRT14 was associated with
a significant increase in TNF-a-induced apoptosis as assessed
by the TUNEL assay (Figure 4a). Similar data were obtained
using levels of activated caspase-3/7 as a marker for
induction of apoptosis in HaCaT cells (Figure 4b). Of note,
even in the absence of TNF-a, although not statistically
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Figure 2. Quantitative assessment of KRT14 RNA levels in NFJS. (a) gDNA
and cDNA derived from a skin punch biopsy obtained from a patient carrying
the p.C18X mutation was PCR-amplified with fluorescently labeled primers,
and the resulting amplicons were digested with mutation-specific
endonuclease DdeI and sized on an ABI 310 sequencer system. Note the
markedly decreased peak (171 bp) in the mutant cDNA sample as compared
with mutant gDNA. (b) gDNA and cDNA samples from patients carrying
mutations p.Q7X, p.C18X, and c.29delC were processed as described above
and AUC was obtained for each fragment using GenScan. The ratio of the
cDNA-derived mutant fragment (McDNA) AUC to the gDNA-derived mutant
fragment (MgDNA) AUC was calculated and normalized relative to the ratio
of the cDNA-derived WT fragment (WcDNA) AUC to the gDNA-derived WT
fragment (WgDNA) AUC.
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Figure 3. NFJS-causing mutations result in null alleles. (a) HaCaT cells were
transiently transfected with a WT and a p.C18X-carrying expression vectors
coding for a full-length K14–EGFP fusion protein. To assess endogenous
KRT14 expression, cell cultures were stained with an anti-KRT14 mAb that
was revealed with a Cy3-conjugated goat anti-mouse antibody. Cells were
counterstained with DAPI. Note the lack of GFP-positive signal in cells
transfected with the mutant construct. (b) Protein levels of K14–EGFP fusion
protein (GFP) are shown for protein extracts derived from HaCaT cells
transfected with WT and p.C18X (C18X)-carrying K14–EGFP expression
vectors. Untransfected cells (UT) served as a negative control and b-actin was
used as an internal control.
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significant, an increased rate of apoptosis was observed in the
HaCaT cells transfected with KRT14-specific siRNA as
compared with cells exposed to control siRNA (Figure 4a).
We therefore suspected that this effect may be due to
increased paracrine secretion of TNF-a, as previously shown
in an in vitro EBS model (Yoneda et al., 2004). However,
identical and very low TNF-a levels were measured by ELISA
in the extracellular medium of HaCaT cell cultures trans-
fected with KRT14-specific or scrambled siRNA (not shown).
As other keratins have been shown to affect keratinocyte
susceptibility to apoptosis (Inada et al., 2001; Tong and
Coulombe, 2006), we assessed the expression of KRT16,
KRT17, and KRT19 both by quantitative real-time reverse
transcription-PCR and by western blotting in HaCaT cells
transfected with KRT14-siRNA and scrambled siRNA. KRT14-
specific siRNA induced an B50% reduction in KRT14
expression but did not significantly affect the level of
expression of other type I keratins (Figure S1).
Effect of doxycycline on TNF-a-mediated apoptosis associated
with decreased KRT14 expression
As decreased K14 expression was found to augment TNF-a-
induced apoptosis, we postulated that interfering with TNF-a-
mediated signaling may attenuate these deleterious effects.
To assess this possibility, we exposed HaCaT cells to TNF-a
and KRT14-specific siRNA in the presence or absence of
doxycycline, which has been shown to protect cells from
TNF-a-mediated apoptosis by interfering with the activation
of effector caspases and matrix metalloproteinases (Festoff
et al., 2006; Shen et al., 2006). As shown in Figure 4c,
doxycycline was able to rescue resistance to TNF-a-induced
apoptosis in K14-deficient HaCaT cells. Indeed, when KRT14
siRNA-treated HaCaT cells were exposed to doxycycline, the
percentage of apoptotic cells decreased from 65%þ28.7
(untreated cells) to 14%þ 5.1 (treated cells) (Po0.05).
DISCUSSION
The spectrum of known functions of intermediate filaments,
in general, and of keratins more specifically, is steadily
expanding (Gu and Coulombe, 2007; Magin et al., 2007).
Interestingly, much of our present knowledge of the role
played by intermediate filaments has emerged from the study
of rare genetic disorders. Seminal studies of a K14 transgenic
murine model for EBS (Vassar et al., 1991) and the ensuing
delineation of the molecular basis of EBS, pachyonychia
congenita, epidermolytic hyperkeratosis, and other related
disorders (reviewed in Omary et al., 2004; Uitto et al., 2007)
initially highlighted the importance of keratin molecules in
cell and tissue resistance to mechanical stress. The subse-
quent discovery of mutations in genes encoding intermediate
filaments in more than 30 human inherited diseases revealed
many additional facets of intermediate filament function in
virtually all body tissues (Coulombe and Wong, 2004). For
example, through the deciphering of the molecular cause of
laminopathies, lamins were found to be involved not only in
the maintenance of proper nucleus shape and integrity, but
also in the regulation of chromatin organization, transcrip-
tional activity, and cell signaling (Capell and Collins, 2006).
Keratins and vimentin were shown to regulate cell growth,
migration, and viscoelasticity (Brown et al., 2001; Beil et al.,
2003; Kim et al., 2006); and finally, null mutations in KRT17
in mice or missense mutations in human KRT8/KRT18
(conferring an increased risk for liver cirrhosis and other
inflammatory gastrointestinal conditions) provided the first
in vivo evidence for a cytoprotective/anti-apoptotic role of
type I keratins (Owens and Lane, 2004; Tong and Coulombe,
2006; Zatloukal et al., 2007). The ability of type I keratins to
bind TRADD, an adapter molecule recruited at the cytoplas-
mic end of the TNF receptor type 1, has been proposed to
underlie keratin anti-apoptotic activity (Inada et al., 2001).
According to this model, keratin-dependant sequestration of
TRADD may down-regulate TNF receptor type 1-mediated
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Figure 4. Decreased expression of KRT14 results in increased susceptibility
of keratinocytes to TNF-a. HaCaT cells were transiently transfected with
KRT14-specific siRNA (K14) or with scrambled control siRNA (CO) and
exposed to TNF-a (þ ) or vehicle (). Apoptotic activity was assessed by
(a) TUNEL assay or (b) assay for activated caspase 3/7 levels. (c) Doxycycline
(Dox) was found to inhibit apoptosis induced by decreased KRT14 expression.
All experiments were repeated three times. Results are provided as meanþ SE.
Results were considered significant for Po0.05.
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TNF-a signaling. However, the anti-apoptotic effect of
cytokeratins may involve additional pathways, as TRADD is
associated with non-TNF-a-mediated signaling as well as
TNF-a-mediated pro-survival signaling, and some of TNF-a
downstream targets are regulated in a non-TRADD-depen-
dant fashion (Wesemann et al., 2004; Jackson-Bernitsas et al.,
2007). Irrespective of the precise mechanisms involved, a
large body of evidence suggests that keratins may function in
epithelial tissues as important regulators of apoptosis
(Oshima, 2002).
The present data, together with a recent report by Lugassy
et al. (2006) provide for the first time evidence that an
inherited human keratinopathy, NFJS, results from impaired
regulation of apoptosis. Indeed, histopathological and electron
microscopic studies indicate increased apoptotic activity in the
epidermal basal layer of NFJS patients. As illustrated in this
study (Figure 1), NFJS-causing mutations are confined to the
amino-terminal E1/V1-encoding region of the KRT14 gene
(Lugassy et al., 2006) and result in K14 haploinsufficiency
(Figures 2 and 3), which, under in vitro conditions, is associated
with increased susceptibility of epidermal cells to TNF-a-
mediated apoptosis (Figure 4). It is important to note that a
residual amount of mutant mRNA was present in skin biopsy
material derived from NFJS patients. Consequently, we cannot
entirely rule out the possibility that a small quantity of N- or
C-truncated K14 molecules may be synthesized in vivo.
Most autosomal-recessive KRT14 mutations associated
with EBS also led to premature termination of translation.
Interestingly, patients with recessive EBS may display
extensive hyperpigmentation (Jonkman et al., 1996). KRT14
premature termination codon mutations in recessive EBS are
located distally relative to dominant NFJS-causing mutations
(http://www.interfil.org/) and do not result in an obvious
phenotype in heterozygous carriers, although the clinical and
skin biopsy features in these individuals have not been
reported in detail. To explain the different consequences of
premature termination codon-associated proximal and distal
heterozygous mutations in KRT14, it has been suggested that
the proximal location of NFJS-causing mutations may lead to
the activation of an alternative ATG, resulting in the synthesis
of N-truncated K14 molecules capable of mediating a
dominant negative effect (Lugassy et al., 2006). However,
in this study, transfection of HaCaT cells with a K14–EGFP
vector carrying an NFJS-causing mutation was not associated
with disruption of the endogenous cell cytoskeleton or with
the generation of an N-truncated K14 protein (Figure 3). In
addition, examination of KRT14 sequence indicates the
presence of two ATG codons in exon 1: the first one
encoding residue M14 is located proximal to C18X and
therefore cannot rescue mRNA carrying this mutation; the
second one encodes residue M119 and is located distal to a
recessive EBS causing mutation (c.92delT) (Batta et al., 2000).
Alternatively, mutations resulting in premature termination of
translation often activate NMD, provided the mutation is
located proximal to the antepenultimate gene exon (Garneau
et al., 2007). Semi-quantitative analysis of mutant RNA levels
in patient skin supports the existence of NMD in NFJS
(Figure 2). It is, therefore, somewhat puzzling that proximally
located heterozygous nonsense/frameshift mutations in
KRT14 result in abnormal epithelial differentiation, whereas
obligatory carriers of similar heterozygous mutations asso-
ciated with recessive EBS and located more distally do not
display any abnormal phenotype (Ciubutaro et al., 2003). It is
possible that recessive mutations in KRT14 are associated
with a lesser degree of NMD. NMD efficiency is often (see
Jeganathan et al., 2002), but not always, influenced by the
position of the eliciting mutations, with 30–50 polar suscepti-
bility to NMD being frequently reported (Wang et al., 2002).
However, available data indicate that recessive mutations in
KRT14 also result in KRT14mRNA decay in vivo (Schuilenga-Hut
et al., 2002; Ciubutaro et al., 2003). More importantly, NFJS
features a large number of developmental non-progressive
defects, such as abnormal fingerprints due to ridge dysplasia,
reticulate hyperpigmentation, or malformation of the nails
and teeth, some of which (e.g., pigmentation) tend to
disappear over time (Itin et al., 1993), suggesting that the
contrasting phenotypic expression of proximal and distal
premature termination codon-causing mutations may possi-
bly result from different levels of interference with develop-
mental processes rather than being of major/direct relevance
to homeostatic maintenance of adult tissues. In this regard, it
has been suggested that the efficiency of NMD varies
throughout development, although the mechanisms regulat-
ing differential NMD activity during embryogenesis are still
poorly understood (Alonso and Akam, 2003).
Although much has been learned over the past 20 years
about the structural role of epithelial keratins, the non-
mechanical functions of these molecules have only recently
been explored (Gu and Coulombe, 2007; Magin et al., 2007).
Deciphering the molecular basis of NFJS has further
broadened the spectrum of functions known to be fulfilled
by these proteins and points to the importance of keratin-
driven regulation of apoptosis during ontogenesis of the
epidermis and the cutaneous appendages.
MATERIALS AND METHODS
Patients
All participants or their legal guardian provided written and
informed consent according to a protocol approved by local IRB
(Institutional Review Board) and by the Committee for Genetic
Studies of the Israeli Ministry of Health in adherence with the
Declaration of Helsinki Principles. DNA was extracted according to
standard procedures. Skin biopsies obtained from pigmented skin
were fixed in formaldehyde for subsequent immunohistochemistry
with anti-K6 (Abcam, Cambridge, UK) and anti-K16 (Thermo
Fischer, Fremont, CA). Skin biopsies were put in RNAlater solution
(Ambion, Austin, TX) and total RNA was extracted using the RNeasy
extraction kit (Qiagen, Valencia, CA).
DNA sequencing
To sequence KRT14 exon 1, gDNA was PCR-amplified using
oligonucleotides F-TACCCGAGCACCTTCTCTTC and R-TGCTGGA
GAACAAGTAGCTGC. PCR conditions were 941C for 5minutes
followed by 10 cycles at 941C for 1minute, 591C for 1minute, 721C
for 1minute 30 seconds. A total of 5 ml of the resulting amplicons
were nested-PCR-amplified using oligonucleotides F-CCGAGC
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ACCTTCTCTTCACT and R-CACTGATCTCACATGGTCTG. PCR
conditions were 941C for 5minutes followed by 34 cycles at 941C
for 1minute, 591C for 1minute, 721C for 1minute 30 seconds.
Gel-purified (QIAquick gel extraction kit, Qiagen) amplicons were
subjected to bidirectional DNA sequencing using the BigDye
terminator system on an ABI Prism 3100 sequencer (PE Applied
Biosystems, Foster City, CA).
DNA chromatography heteroduplex analysis
To confirm and screen for 29delC mutation, we used WAVE analysis
(Transgenomic Inc., Omaha, NE). PCR products were denatured at
951C for 5minutes and cooled to 651C down a temperature gradient
of 11C minute1. A total of 5 ml of each sample was applied to a
preheated C18 reversed-phase column based on non-porous
polystyrene-divinyl-benzene particles (DNA-Sep Cartridge, Transge-
nomic Inc.). DNA was eluted within a linear acetonitrile gradient
consisting of buffer A (0.1 M triethylammonium acetate/buffer B
(0.1 M triethylammonium acetate, 25% acetonitrile) (Transgenomic
Inc.). The melting profile of the DNA fragment was determined using
Wavemaker 4.2 software and the Stanford DNA chromatography
heteroduplex analysis melting program (http://insertion.stanford.edu/
meltdoc.html) (Bercovich and Beaudet, 2003).
Quantitative PCR–restriction fragment length polymorphism
Total RNA was extracted from skin biopsies using the RNeasy mini
kit (Qiagen). cDNA was synthesized from 1 mg of total RNA using the
Reverse-iT first strand synthesis kit (ABgene, Epsom, UK) and random
hexamers. cDNA and gDNA were PCR-amplified using FAM-labeled
oligonucleotide R-GCTGAAGCCACCGCCATAG and non-labeled
oligonucleotide F-CCGAGCACCTTCTCTTCACT (for mutations Q7X
and C18X) and F-CATGACTACCTGCAGCCGCCAGTTCACCGC (for
mutation 29delC). The resulting amplicons were digested using BfaI
(mutation Q7X), DdeI (mutation C18X), and BsrBI (mutation 29delC)
endonucleases and were analyzed on an ABI Prism 310 sequencer
using GeneScan and Genotyper software (PE Applied Biosystems).
Area under the curve (AUC) (see Figure 2) was calculated using
GeneScan Analysis 2.1 software (PE Applied Biosystems).
Plasmids
The Pcr3.1-K14/GFP plasmid, containing the entire coding region of
KRT14 fused to the EGFP coding sequence, was kindly provided by
Dr Irwin Mclean. Mutation p.C18X was introduced into the Pcr3.
1-K14/GFP plasmid by site-directed mutagenesis using the Quik-
Change II XL Site-directed mutagenesis kit (Invitrogen, Carlsbad, CA)
and oligonucleotides CTCCATGAAGGGCTCCTGAGGCATCGGGG
GCGGCATCGG and CCGATGCCGCCCCCGATGCCTCAGGAGCC
CTTCATGGAG. The resulting construct was verified by direct
sequencing.
Cell cultures and plasmid transfection
HaCaT cells, a long-lived, spontaneously immortalized human
keratinocyte line, were kindly provided by Dr Amiram Ravid. The
cells were maintained in MEM-Eagle’s medium supplemented with
10% fetal calf serum, 1% L-glutamine and 1% penicillin/streptomy-
cin. Doxycycline was added at a final concentration of 1 mg ml1
(Seibler et al., 2007).
Cells were transfected with 2mg plasmid DNA using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s instructions.
Immunofluorescence microscopy
Cells were grown on glass coverslips, fixed with methanol, and
incubated with an mAb against cytokeratin 14 (BioGenex, San
Ramon, CA) for 60minutes at 201C. Staining was detected after
incubation with Cy3-conjugated goat anti-mouse antibody (ABcam,
Cambridge, UK). The slides were observed under a confocal
microscope (Axiovert 200M LSM 510 Meta, Carl Zeiss MicroImaging
GmbH, Go¨ttingen, Germany) using Image-Pro Plus LSM image
examiner software (Media Cybernetics, MD).
siRNA transfection
HaCaT cells were cultured in six-well plates before transfection with
50nmol l1 siRNA duplexes against KRT14 using LipofectAMINE 2000
(Invitrogen, Carlsbad, CA). The siRNA duplex used consisted of 50-rG
rGrCrArUrCrArAUrArCrArGrCUUrCrATT-30 and 50-UrGrArArGrCUr
GUrAUUrGrAUUrGrCrCTT-30 (Sigma-Proligo, The Woodlands, TX).
Apoptosis assays
To induce apoptosis, we used TNF-a at a concentration of 2 ng ml1.
TUNEL assays were performed with an in situ cell death detection
kit, TMR red (Roche, Mannheim, Germany). Cells were air-dried and
fixed with a freshly prepared fixation solution (4% paraformaldehyde
in phosphate-buffered saline) and then rinsed twice with phosphate-
buffered saline. Cells were permeabilized with 0.1% Triton X-100 in
0.1% sodium citrate. Cell samples were incubated in a humidified
atmosphere for 1 hour at 371C in the dark in the presence of the
TUNEL reaction mixture and counterstained with DAPI.
Caspase-3 assay was performed using carboxy-fluorescein FLICA
(fluorochrome inhibitor of caspases) apoptosis detection kit caspase
assay (Immunochemistry Technology, LLC, Bloomington, MN).
FLICA solution was added to cell culture medium at a 1:30 ratio
and cells were incubated for 1 hour at 371C under 5% CO2 in the
dark. Hoechst stain was used to counterstain the cells.
More than 1,000 cells were counted for each slide and examined
under a fluorescent microscope Axioscope 2 (Carl Zeiss MicroIma-
ging GmbH). Image analysis was performed with Image-Pro Plus
software. Differences in apoptotic activity were considered sig-
nificant at P-values o0.05 calculated using a standard Student’s t-
test.
TNF-a ELISA
Human TNF-a—ELIZA MAX kit (Biolegend, San Diego, CA) was
used to detect TNF-a in the media of siRNA-transfected HaCaT cells,
according to the manufacturer’s instructions.
Quantitative reverse transcription-PCR
For quantitative real-time PCR, cDNA was synthesized from 1 mg of
total RNA using the Reverse-iT first strand synthesis kit (ABgene) and
random hexamers. cDNA PCR amplification was carried out using
the Absolute QPCR SYBR Green Mix (ABgene) on an M 3000p/5p
multi-filter system (Stratagene, Cedar Creek, TX) with oligonucleo-
tide pairs specific for KRT14 (F-GATCAAAGACTACAGTCCCTAC
and R-CTCAATCTGCATCTCCAG) or ACTB (F-TTGCCGACAG
GATGCAGAAGGA and R-AGGTGGACAGCGAGGCCAGGAT). To
ensure the specificity of the reaction conditions, at the end of the
individual runs, the melting temperature (Tm) of the amplified
products was measured to confirm its homogeneity. Cycling
conditions were as follows: 951C for 10minutes, 951C for
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10 seconds, 621C for 15 seconds, and 721C for 25 seconds for a
total of 40 cycles. Each sample was analyzed in triplicate. For
quantification, standard curves were obtained using serially diluted
cDNA amplified in the same real-time PCR run. Results were
normalized to ACTB mRNA levels. After the quantification
procedure, the products were resolved by 2.5% agarose gel
electrophoresis to confirm that the reaction had amplified the
correct DNA fragments of known size.
Western blotting
Cells were homogenized in lysis buffer (25mM HEPES, 300mM NaCl,
1.5mM MgCl2, 0.2mM EDTA and protease inhibitors mix, including
1mM PMSF, 1mg ml1 aprotinin and leupeptin; Sigma, St Louis,
MO) or directly in loading buffer (100mM Tris pH¼ 6.8, 4% SDS,
20% glycerol, 0.2% bromophenol blue). Following centrifugation at
10,000 g for 10minutes at 41C, proteins were electrophoresed
through a 10% SDS-PAGE and transferred onto a nitrocellulose
membrane (Trans-Blot Bio-Rad, Hercules, CA). After 1 hour blocking
with 1 Tris-buffered saline (20mM Tris, 150mM NaCl) with 5%
skimmed milk and 0.01% Tween 20, blots were incubated with
primary antibodies (mouse monoclonal anti-EGFP antibody, Santa
Cruz Biotechnology, Santa Cruz, CA; rabbit anti-K14, Covance,
Berkeley, CA; anti-K17 and anti-K19, Abcam, Cambridge, UK). The
blots were washed three times with Tris-buffered saline–Tween
(20mM Tris HCl, 4mM Tris base, 140mM NaCl, 1mM EDTA, 0.1%
Tween-20). After incubation with secondary horseradish peroxidase-
conjugated anti-mouse antibody (Sigma-Aldrich, Rehovot, Israel)
and subsequent washings, proteins were detected using the
EZ-ECL chemiluminescence detection kit (Biological Industries, Beit
Haemek, Israel).
To compare the amount of protein in the different samples,
the blots were re-probed with mouse mAb to b-actin (ABcam,
Cambridge, UK) and secondary horseradish peroxidase-conjugated
anti-mouse antibody (Sigma-Aldrich).
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Figure S1. Effect of KRT14-siRNA on type I keratin expression.
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